NumerixS Investment Technologies Inc bought a new position in shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) during the 1st quarter, according to its most recent disclosure with the SEC. The fund bought 3,800 shares of the company’s stock, valued at approximately $212,000.

Several other large investors have also made changes to their positions in the company. BlackRock Inc. raised its stake in Tabula Rasa HealthCare by 1.6% during the fourth quarter. BlackRock Inc. now owns 2,600,884 shares of the company’s stock worth $165,831,000 after purchasing an additional 40,174 shares during the period. Fiera Capital Corp purchased a new stake in Tabula Rasa HealthCare in the 4th quarter valued at $2,268,000. Polar Capital LLP acquired a new position in shares of Tabula Rasa HealthCare during the 4th quarter worth $3,953,000. Nicholas Company Inc. grew its stake in Tabula Rasa HealthCare by 6.5% in the 4th quarter. Nicholas Company Inc. now owns 77,485 shares of the company’s stock valued at $4,940,000 after acquiring an additional 4,750 shares during the last quarter. Finally, Summit Creek Advisors LLC acquired a new stake in Tabula Rasa HealthCare in the 1st quarter valued at about $2,885,000. 86.66% of the stock is currently owned by institutional investors.

Several research analysts have recently weighed in on the stock. Cantor Fitzgerald reiterated a “buy” rating and set a $99.00 price objective on shares of Tabula Rasa HealthCare in a report on Thursday, February 28th. Zacks Investment Research cut Tabula Rasa HealthCare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 8th. BidaskClub upgraded Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a research note on Tuesday, May 7th. ValuEngine cut shares of Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research note on Monday, May 13th. Finally, Guggenheim initiated coverage on Tabula Rasa HealthCare in a report on Wednesday, April 17th. They set a “neutral” rating and a $58.00 target price on the stock. Five investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. Tabula Rasa HealthCare has a consensus rating of “Buy” and a consensus price target of $82.12.

In related news, CEO Calvin H. Knowlton sold 8,270 shares of the company’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $53.68, for a total transaction of $443,933.60. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, President Orsula V. Knowlton sold 8,000 shares of the company’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $58.10, for a total transaction of $464,800.00. The disclosure for this sale can be found here. Insiders have sold 48,270 shares of company stock valued at $2,462,254 over the last quarter. Company insiders own 14.00% of the company’s stock.

Tabula Rasa HealthCare stock traded up $2.53 during midday trading on Wednesday, reaching $47.88. The stock had a trading volume of 7,509 shares, compared to its average volume of 384,464. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.80 and a quick ratio of 1.73. The firm has a market capitalization of $964.41 million, a price-to-earnings ratio of 138.65 and a beta of 1.68. Tabula Rasa HealthCare Inc has a 12 month low of $40.86 and a 12 month high of $91.16.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Wednesday, May 8th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.14). The firm had revenue of $60.96 million for the quarter, compared to the consensus estimate of $59.24 million. Tabula Rasa HealthCare had a positive return on equity of 4.22% and a negative net margin of 18.15%. On average, sell-side analysts expect that Tabula Rasa HealthCare Inc will post -0.55 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “NumerixS Investment Technologies Inc Buys New Holdings in Tabula Rasa HealthCare Inc (NASDAQ:TRHC)” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.thecerbatgem.com/2019/06/12/numerixs-investment-technologies-inc-buys-new-holdings-in-tabula-rasa-healthcare-inc-nasdaqtrhc.html.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.

Featured Story: What is Green Investing?

Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).

Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.